Clinical Research: Phase 1 - Phase 4
Premier Insight 265: Exceeding Expectations: Durable Remission in Diffuse Large B-Cell Lymphoma
When a developer of a CD19-directed cytolytic antibody for B-cell Lymphoma engaged Premier Research to assist with screening and enrollment in a global Phase 2 study, the Premier project team devised an operational strategy with a goal to exceed expectations. Despite several challenges, the enrollment was completed three months ahead of schedule thanks to consistent...